Ansøgeren forelagde dokumentation for virkningen af de aktive indholdsstof doxycyclin mod M. hyopneumoniae hos svin, baseret på publikationer og MIC - bestemmelser.
The applicant provided evidence of efficacy of the active substance, doxycycline, against M. hyopneumoniae in pigs from published literature and from MIC studies.